Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Published online Aug 15, 2026. doi: 10.4239/wjd.123635
Table 4 Comparison of plasma peroxiredoxin family member expression between the control and observation group
| Indicators | Control group | Observation group | Z/χ2 | P value |
| Number of cases | 222 | 222 | ||
| PRDX1 (pg/mL) | 46.23 (32.35-102.41) | 126.20 (68.99-183.65) | 9.385 | 0.000 |
| PRDX2 (pg/mL) | 58.00 (32.76-87.44) | 77.30 (54.13-120.30) | 4.367 | 0.000 |
| PRDX3 (pg/mL) | 150.93 (102.83-190.35) | 175.00 (125.95-236.05) | 4.591 | 0.000 |
| PRDX4 (pg/mL) | 71.23 (39.20-117.74) | 141.30 (91.19-170.80) | 10.069 | 0.000 |
| PRDX5 (pg/mL) | 65.25 (47.44-125.00) | 123.60 (93.10-150.68) | 8.825 | 0.000 |
| PRDX6 (pg/mL) | 413.95 (256.45-525.00) | 472.45 (270.46-652.30) | 3.244 | 0.001 |
- Citation: Xu XP, Ding S, Che YM, Li J, Zhang Z, Qian C. Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus. World J Diabetes 2026; 17(8): 123635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123635.htm
- DOI: https://dx.doi.org/10.4239/wjd.123635